Group One Trading’s Pliant Therapeutics PLRX Stock Holding History

Group One Trading’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,790	Closed	-$19.9K	–	8483
2025 Q4	$19.3K	Buy	15,790 +12,669	+406%	+$19K	﹤0.01%	6360
2025 Q3	$4.62K	Sell	3,121 -1,500	-32%	-$2.29K	﹤0.01%	7582
2025 Q2	$5.36K	Sell	4,621 -100	-2%	-$141	﹤0.01%	7057
2025 Q1	$6.37K	Sell	4,721 -5,788	-55%	-$35.1K	﹤0.01%	6531
2024 Q4	$138K	Buy	10,509 +1,396	+15%	+$19.1K	﹤0.01%	4243
2024 Q3	$102K	Sell	9,113 -2,750	-23%	-$34.4K	﹤0.01%	4159
2024 Q2	$128K	Hold	11,863	–	–	﹤0.01%	3764
2024 Q1	$177K	Sell	11,863 -1,034	-8%	-$17.1K	﹤0.01%	3670
2023 Q4	$234K	Buy	12,897 +5,260	+69%	+$80K	﹤0.01%	3731
2023 Q3	$132K	Buy	+7,637	New	+$132K	﹤0.01%	4194
2023 Q2	–	Sell	-10,372	Closed	-$246K	–	8088
2023 Q1	$276K	Buy	+10,372	New	+$295K	﹤0.01%	3366

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Group One Trading's PLRX Position: Q1 2026 in Review

Group One Trading sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 15,790 shares — an estimated $19.9K sold.

Group One Trading first reported a position in PLRX in Q1 2023 and held it in 11 quarters. The position peaked at $276K in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

Group One Trading reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 15,790 Pliant Therapeutics shares in Q1 2026, an estimated $19.9K.
Group One Trading first reported a position in Pliant Therapeutics in Q1 2023 and held it in 11 quarters.
Group One Trading's Pliant Therapeutics position peaked at $276K in Q1 2023.
91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.